This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Celecoxib versus diclofenac trial

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The trial enrolled 655 patients with adult-onset rheumatoid arthritis and compared the anti-inflammatory efficacy and the gastrointestinal side-effects of celecoxib versus diclofenac.

The trial had a double-blind, double-dummy, randomised, parellel design.

Anti-inflammatory effects were assessed every four weeks for 24 weeks. 430 patients received an upper GI endoscopy to assess the presence of ulceration.

Reference:

  • Emery, P. et al. (1999) "Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison". Lancet, 354, 2106-11.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.